Keywords = Immunotherapy
Number of Articles: 17
1. Effect of Primary Systemic Therapy on PD-1, PD-L1, and PD-L2 mRNA Expression in Advanced Breast Cancer

Volume 22, Issue 7, July 2021, Pages 2069-2077

Ramadhan Karsono; Muhammad Al Azhar; Yulia Pratiwi; Fahreza Saputra; Siti Nadliroh; Teguh Aryandono

2. Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival

Volume 22, Issue 6, June 2021, Pages 1883-1889

Mayada Saad Farrag; Eman Mohamad Ibrahim; Tamer A. El-Hadidy; Mohamed Farouk Akl; Alyaa R. Elsergany; Heba Wagih Abdelwahab

4. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung

Volume 22, Issue 2, February 2021, Pages 365-370

Takefumi Komiya; Neema Ravindra; Emily Powell

5. Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma

Volume 20, Issue 10, October 2019, Pages 2951-2957

Deepika Chandrasekaran; Sandhya Sundaram; Kadhiresan N; Padmavathi R

6. Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors

Volume 20, Issue 4, April 2019, Pages 1161-1169

Wilasinee Nhokaew; Pilaiwan Kleebkaow; Nipon Chaisuriya; Chumnan Kietpeerakool

7. Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy

Volume 18, Issue 7, July 2017, Pages 1827-1832

Bushra Sikandar; Muhammad Asif Qureshi; Saima Naseem; Saeed Khan; Talat Mirza

8. Expression of Cancer-Testis Antigens in Pediatric Cancers

Volume 16, Issue 13, December 2015, Pages 5149-5152

15. Snake Venom: A Potent Anticancer Agent

Volume 13, Issue 10, October 2012, Pages 4855-4860